EA200301126A1 - Противоопухолевая композиция, содержащая толуолсульфонамид, и способ ее применения - Google Patents

Противоопухолевая композиция, содержащая толуолсульфонамид, и способ ее применения

Info

Publication number
EA200301126A1
EA200301126A1 EA200301126A EA200301126A EA200301126A1 EA 200301126 A1 EA200301126 A1 EA 200301126A1 EA 200301126 A EA200301126 A EA 200301126A EA 200301126 A EA200301126 A EA 200301126A EA 200301126 A1 EA200301126 A1 EA 200301126A1
Authority
EA
Eurasian Patent Office
Prior art keywords
toluolsulphonamide
application
composition containing
compositions
tumor composition
Prior art date
Application number
EA200301126A
Other languages
English (en)
Other versions
EA007685B1 (ru
Inventor
Джон Ву
Роки К. С. Ших
Лестер Ву
Original Assignee
Пи Ти Эс ИНТЕРНЭШНЛ, ИНК.
Роки К. С. Ших
Лестер Ву
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пи Ти Эс ИНТЕРНЭШНЛ, ИНК., Роки К. С. Ших, Лестер Ву filed Critical Пи Ти Эс ИНТЕРНЭШНЛ, ИНК.
Publication of EA200301126A1 publication Critical patent/EA200301126A1/ru
Publication of EA007685B1 publication Critical patent/EA007685B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

Настоящее изобретение относится к композиции, обладающей противоопухолевой активностью и содержащей толуолсульфонамид в концентрации, которая ранее не была известна как концентрация, эффективная для этих целей. Указанные композиции обладают способностью ингибировать рост опухоли, уменьшать размер опухоли (то есть подвергать опухоль некрозу) и предупреждать образование опухоли у человека. Настоящее изобретение также относится к способам получения и применения указанных композиций.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200301126A 2001-04-16 2002-04-16 Фармацевтическая композиция, содержащая толуолсульфонамид, и способы ее получения и применения EA007685B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/835,908 US6727287B2 (en) 2001-04-16 2001-04-16 Toluene sulfonamide-containing anti-tumor composition and method of use thereof
PCT/US2002/011786 WO2002083117A1 (en) 2001-04-16 2002-04-16 Toluene sulfonamide-containing anti-tumor composition and method of use thereof

Publications (2)

Publication Number Publication Date
EA200301126A1 true EA200301126A1 (ru) 2004-06-24
EA007685B1 EA007685B1 (ru) 2006-12-29

Family

ID=25270767

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200301126A EA007685B1 (ru) 2001-04-16 2002-04-16 Фармацевтическая композиция, содержащая толуолсульфонамид, и способы ее получения и применения

Country Status (17)

Country Link
US (1) US6727287B2 (ru)
EP (1) EP1389101B1 (ru)
JP (1) JP2004526760A (ru)
CN (1) CN100471491C (ru)
AT (1) ATE415960T1 (ru)
AU (1) AU2002303350B2 (ru)
BR (1) BR0208961A (ru)
CA (1) CA2444842A1 (ru)
DE (1) DE60230133D1 (ru)
EA (1) EA007685B1 (ru)
ES (1) ES2316565T3 (ru)
HK (1) HK1067545A1 (ru)
IL (2) IL158433A0 (ru)
MX (1) MXPA03009483A (ru)
NZ (1) NZ529513A (ru)
WO (1) WO2002083117A1 (ru)
ZA (1) ZA200308814B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005005397B4 (de) * 2005-02-05 2008-08-21 Lts Lohmann Therapie-Systeme Ag Isolierung von N-Butylbenzolsulfonamid, Synthese von Benzolsulfonamid-Derivaten sowie Verwendung von N-Butylbenzolsulfonamid und Benzolsulfonamid-Derivaten zur Behandlung der benignen Prostatahyperplasie und/oder des Prostatakarzinoms
US7790928B1 (en) * 2005-04-25 2010-09-07 Albert Raymond Hechinger Therapeutic dimethyl sulfoxide (aka DMSO) compositions and methods of use
WO2007076875A2 (en) * 2006-01-06 2007-07-12 Aarhus Universitet Compounds acting on the serotonin transporter
CN104473914B (zh) * 2015-01-06 2017-01-11 天津红日药业股份有限公司 一种磺酰胺类药物组合物
US10465742B2 (en) 2015-10-29 2019-11-05 Inteva Products, Llc Cable end fitting and cable abutment and method of securement
US9782370B2 (en) 2015-12-21 2017-10-10 Gongwin Biopharm Holdings Co., Ltd. Pharmaceutical compositions of benzenesulfonamide derivatives for treatment of adenoid cystic carcinoma
US9668990B1 (en) 2016-06-10 2017-06-06 Gongwin Biopharm Holdings Co., Ltd. Benzenesulfonamides compositions for treatment of malignant pleural effusions
US10182998B2 (en) * 2016-06-10 2019-01-22 Gongwin Biopharm Holdings Co., Ltd. Benzenesulfonamide compositions for treatment of malignant pleural effusions
US20180055796A1 (en) * 2016-08-23 2018-03-01 Gongwin Biopharm Holdings Co., Ltd. Pharmaceutical composition exhibiting anti-tumor activity, method for treating patient suffering from cancer and method for inhibiting tumor growth
WO2019133797A1 (en) * 2017-12-29 2019-07-04 Wu, Lester J. Benzenesulfonamide derivatives and method for modulating lipid raft

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340148A (en) 1961-03-22 1967-09-05 Gillette Inhibitor Co Treatment of fungus diseases of the skin
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4160452A (en) 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4777049A (en) 1983-12-01 1988-10-11 Alza Corporation Constant release system with pulsed release
US4663308A (en) 1984-07-18 1987-05-05 Medical College Of Ohio Method of use of polymers containing cross-linked azo bonds for releasing therapeutic agents into the lower gastrointestinal tract
US4764381A (en) 1985-12-06 1988-08-16 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol
US4983396A (en) 1985-12-06 1991-01-08 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1,3-hexanediol
US5891454A (en) 1997-03-28 1999-04-06 Alexander Wu Anti-cancer drug and special tumor necrotizing agent
CN1073415C (zh) 1997-07-03 2001-10-24 吴宜庄 磺酰胺类化合物在制备抗癌药物中的应用

Also Published As

Publication number Publication date
JP2004526760A (ja) 2004-09-02
EP1389101A1 (en) 2004-02-18
HK1067545A1 (en) 2005-04-15
ES2316565T3 (es) 2009-04-16
MXPA03009483A (es) 2004-12-06
BR0208961A (pt) 2005-02-01
CN1511032A (zh) 2004-07-07
NZ529513A (en) 2005-10-28
DE60230133D1 (de) 2009-01-15
ATE415960T1 (de) 2008-12-15
IL158433A0 (en) 2004-05-12
EP1389101A4 (en) 2005-05-04
US6727287B2 (en) 2004-04-27
EP1389101B1 (en) 2008-12-03
AU2002303350B2 (en) 2007-08-02
IL158433A (en) 2010-11-30
CN100471491C (zh) 2009-03-25
US20030022843A1 (en) 2003-01-30
EA007685B1 (ru) 2006-12-29
WO2002083117A1 (en) 2002-10-24
ZA200308814B (en) 2004-11-23
CA2444842A1 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
DE60029799D1 (de) Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
ATE419253T1 (de) Inhibitoren von thienopyridin- und furopyridinkinase
DE69809726T2 (de) Substituierte analoge von indol-3-carbinol und von diindolmethan als antiestrogene
BG66084B1 (bg) Циклопентаноиндоли, състави,съдържащи такива съединения и използването им
DK1093819T3 (da) Forbindelse og præparat til tilförsel af aktive midler
AU2002319814A1 (en) Substituted 1h-dihydropyrazoles, their preparation and use
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
DE69928655D1 (de) Substituierte porphyrine
BR0215360A (pt) Derivados de indolina úteis como inibidores de proteìna quinase
PT1083903E (pt) Indenopirrolocarbazoles em ponte
EA200600440A1 (ru) 4-((феноксиалкил)тио)еноксиуксусные кислоты и их аналоги
IL153680A0 (en) Aplidine derivatives and methods for the preparation thereof
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
EA200301126A1 (ru) Противоопухолевая композиция, содержащая толуолсульфонамид, и способ ее применения
ATE238981T1 (de) Antitumorwirkstoffe
CY1105345T1 (el) Φαινυλαλκινια
ATE386525T1 (de) 3-substituierte 6,7- dihydroxytetrahydroisochinolin-derivate zur verwendung als antibkaterielle mittel
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
EA200300448A1 (ru) Композиции, включающие соединения модафинила
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
ATE393624T1 (de) Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs
EA200000522A1 (ru) 5-htагонисты
BRPI0410026A (pt) derivados de 3-amino-croman quinolina
EA200201154A1 (ru) Бис(n,n'-бис(2-галоэтил)амино)фосфороамидаты в качестве противоопухолевых агентов
DE60334289D1 (de) Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU